Prognostic and predictive value of the Immunoscore in stage III colon cancer patients treated with oxaliplatin in the prospective IDEA France PRODIGE-GERCOR cohort study

Defective mismatch repair status as a prognostic biomarker of disease-free survival in stage III colon cancer patients treated with adjuvant FOLFOX chemotherapy. Defective

The analysis of surface latent heat flux (SLHF) from the epicentral regions of five recent earthquakes that occurred in close proximity to the oceans has been found to show

Effectuez chaque expression à l’aide de la priorité correcte

subgroup of resected jaundiced patients and poor long-term survival were positive for. inter-aortocaval lymph

Biomarkers are needed to guide the standard of care, such as adjuvant chemotherapy in stage III colon cancer or neoadjuvant chemoradiotherapy (nCRT) in locally advanced rectal

Objectives: To evaluate the performances of systematic posttreatment pelvic magnetic resonance imaging (PPMRI) in predicting prognosis of patients treated with

Overall Survival Following Neoadjuvant Chemotherapy vs Primary Cytoreductive Surgery in Women With Epithelial Ovarian Cancer: Analysis of the National Cancer Database.. Rauh-Hain

For lung cancer diagnosed at the metastatic stage, one-year and two-year survival was not associated with the population density of the municipality of residence.. Despite a